International Myeloma Foundation (IMF) and International
STOCKHOLM, June 09, 2026 (GLOBE NEWSWIRE) — The International Myeloma Foundation (IMF) and the International Myeloma Working Group…
Artificial intelligence-based tool could improve multiple myeloma treatment decisions
An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to…
Adult weight gain strongly linked to higher obesity-related cancer risk
New research presented at this year’s European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows…
XPOVIO® Receives Reimbursement Approval in South Korea for a Second Multiple Myeloma Indication
– XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea’s National Health Insurance Service (NHIS)…